{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:08:01Z","timestamp":1793459281675,"version":"4.5.0"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background and objective<\/jats:title>\n                    <jats:p>The increasing prevalence of atopic dermatitis (AD) has raised concerns about whether individuals with AD require specific cardiovascular disease (CVD) prevention strategies. This study investigated the association between AD and CVD among middle-aged adults.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a nested case\u2013control study using data from the Kyoto Claim Database (April 2013\u2013March 2023) among individuals aged 40\u201359 years who were followed for \u2265 3 years. Cases were patients with first-onset CVD (hospitalization for ischemic heart disease or stroke), whereas controls had no history of CVD. AD was defined by an ICD-10 code (L20) plus a topical corticosteroid (TCS) prescription. For each case, 10 controls were matched on age, sex, index month, hypertension, diabetes, dyslipidemia, hyperuricemia, and use of anticoagulant or antiplatelet agents. Logistic regression was used to assess associations between CVD and AD prevalence or severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 2,757 CVD cases, including 1,247 with ischemic heart disease and 1,563 with stroke (median age 53 years [interquartile range, 49\u201356]; 2,031 [73.7%] male). Comorbidities included hypertension in 1,430 (51.9%), diabetes in 583 (21.1%), dyslipidemia in 1,018 (36.9%), hyperuricemia in 307 (11.1%), and anticoagulant or antiplatelet prescriptions in 377 (13.7%). The median follow-up period was 60 months. After matching, 2,672 cases and 26,720 controls were compared. AD was diagnosed in 66 cases (2.5%) and 728 controls (2.7%), with no significant association between AD and CVD (odds ratio [OR], 0.90; 95% confidence interval, 0.69\u20131.16). Regarding AD severity, 3 cases (0.1%) and 76 controls (0.3%) were in the top 10% of average monthly TCS dose (\u226537.8 g\/month); 28 cases (1.0%) and 352 controls (1.3%) received class 1 TCS; and 14 cases (0.5%) and 144 controls (0.5%) received systemic treatment (immunosuppressants or biologics). AD severity was not associated with CVD risk (ORs: 0.39 [0.10\u20131.05], 0.79 [0.53\u20131.15], and 0.97 [0.53\u20131.62], respectively). A limitation of this study was potential misclassification of AD status due to the nature of claims data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among adults aged 40\u201359 years, AD was not significantly associated with an increased risk of CVD onset, even in severe cases. Targeted CVD screening for patients with AD may not be necessary; however, comprehensive management of standard CVD risk factors remains essential, as in the general population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0341337","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:47:47Z","timestamp":1769194067000},"page":"e0341337","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular risk among middle-aged Japanese adults with atopic dermatitis: A nested case\u2013control study"],"prefix":"10.1371","volume":"21","author":[{"given":"Misato","family":"Maeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5056-8997","authenticated-orcid":true,"given":"Mami","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Tamagawa-Mineoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ikai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"10247","key":"pone.0341337.ref001","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"SM Langan","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"pone.0341337.ref002","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic Dermatitis","volume":"384","author":"S St\u00e4nder","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0341337.ref003","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017","volume":"184","author":"MR Laughter","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"pone.0341337.ref004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","article-title":"Atopic dermatitis and the atopic march revisited","volume":"69","author":"SC Dharmage","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"pone.0341337.ref005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/all.13085","article-title":"Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis","volume":"72","author":"A Egeberg","year":"2017","journal-title":"Allergy"},{"issue":"5","key":"pone.0341337.ref006","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis-what does the evidence say?","volume":"151","author":"JP Thyssen","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"10440","key":"pone.0341337.ref007","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"10440","key":"pone.0341337.ref008","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"pone.0341337.ref009","article-title":"Inflammation as a cardiovascular risk factor","volume":"109","author":"JT Willerson","year":"2004","journal-title":"Circulation"},{"issue":"12","key":"pone.0341337.ref010","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2015.05.041","article-title":"Increased Prevalence of Coronary Artery Disease in Severe Psoriasis and Severe Atopic Dermatitis","volume":"128","author":"KF Hjuler","year":"2015","journal-title":"Am J Med"},{"issue":"2","key":"pone.0341337.ref011","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/07853890.2013.870018","article-title":"Atopic dermatitis and risk of ischemic stroke: a nationwide population-based study","volume":"46","author":"VY-F Su","year":"2014","journal-title":"Ann Med"},{"issue":"10","key":"pone.0341337.ref012","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12685","article-title":"Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies","volume":"70","author":"JI Silverberg","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"pone.0341337.ref013","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"YMF Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"pone.0341337.ref014","article-title":"Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study","volume":"6","author":"JL Riis","year":"2016","journal-title":"BMJ Open"},{"key":"pone.0341337.ref015","article-title":"Severe and predominantly active atopic eczema in adulthood and long term risk of cardiovascular disease: population based cohort study","volume":"361","author":"RJ Silverwood","year":"2018","journal-title":"BMJ"},{"issue":"4","key":"pone.0341337.ref016","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/bjd.15727","article-title":"Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project","volume":"177","author":"AM Drucker","year":"2017","journal-title":"Br J Dermatol"},{"issue":"10","key":"pone.0341337.ref017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/all.12957","article-title":"Atopic dermatitis is not independently associated with nonfatal myocardial infarction or stroke among US women","volume":"71","author":"AM Drucker","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"pone.0341337.ref018","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/bjd.16215","article-title":"The association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis: a systematic review and meta-analysis","volume":"178","author":"JP Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"issue":"49","key":"pone.0341337.ref019","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013512","article-title":"Relationship of atopic dermatitis with stroke and myocardial infarction: A meta-analysis","volume":"97","author":"M Yuan","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pone.0341337.ref020","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.14495","article-title":"Atopic dermatitis is associated with autoimmune but not with cardiovascular comorbidities in a random sample of the general population in Leipzig, Germany","volume":"32","author":"R Treudler","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"pone.0341337.ref021","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jaci.2018.11.030","article-title":"Atopic eczema and major cardiovascular outcomes: a systematic review and meta-analysis of population-based studies","volume":"143","author":"A Ascott","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"pone.0341337.ref022","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2340\/00015555-3235","article-title":"Association Between Atopic Dermatitis and Cardiovascular Disease: A Nationwide Register-based Case-control Study from Sweden","volume":"99","author":"LU Ivert","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"pone.0341337.ref023","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s13555-021-00587-9","article-title":"The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis","volume":"11","author":"JJ Wu","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"pone.0341337.ref024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-021-02240-z","article-title":"Controversial cardiovascular and hematologic comorbidities in atopic dermatitis","volume":"314","author":"K Pandher","year":"2022","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"pone.0341337.ref025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4168\/aair.2023.15.2.231","article-title":"Incidence of Cardiovascular Disease After Atopic Dermatitis Development: A Nationwide, Population-Based Study","volume":"15","author":"SW Lee","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"pone.0341337.ref026","doi-asserted-by":"crossref","first-page":"100338","DOI":"10.1016\/j.jacig.2024.100338","article-title":"Incidence of cardiovascular events in a population-based Danish cohort with atopic dermatitis","volume":"3","author":"A Egeberg","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"5","key":"pone.0341337.ref027","doi-asserted-by":"crossref","first-page":"636","DOI":"10.4168\/aair.2023.15.5.636","article-title":"Atopic Dermatitis and the Risk of Myocardial Infarction and All-Cause Mortality: A Nationwide Population-Based Cohort Study","volume":"15","author":"YR Woo","year":"2023","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"pone.0341337.ref028","doi-asserted-by":"crossref","first-page":"576","DOI":"10.36849\/JDD.7424","article-title":"Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases","volume":"22","author":"AD Pagan","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"pone.0341337.ref029","article-title":"Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis","volume":"11","author":"J Wan","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"pone.0341337.ref030","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ced\/llae164","article-title":"Atopic dermatitis is associated with an increased risk of cardiovascular diseases: a large-scale, propensity-score matched US-based retrospective study","volume":"49","author":"H Zirpel","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"pone.0341337.ref031","doi-asserted-by":"crossref","first-page":"101035","DOI":"10.1016\/j.waojou.2025.101035","article-title":"Cardiovascular and metabolic outcomes associated with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis","volume":"18","author":"S Untaaveesup","year":"2025","journal-title":"World Allergy Organ J"},{"issue":"5","key":"pone.0341337.ref032","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/bjd.19597","article-title":"Atopic eczema and obesity: a population-based study","volume":"184","author":"A Ascott","year":"2021","journal-title":"Br J Dermatol"},{"issue":"4","key":"pone.0341337.ref033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2014.12.013","article-title":"Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis","volume":"72","author":"A Zhang","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"pone.0341337.ref034","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2340\/00015555-3175","article-title":"Comorbidities Associated with Severity of Atopic Dermatitis in Young Adult Males: A National Cohort Study","volume":"99","author":"WL Kok","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"pone.0341337.ref035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjd.20661","article-title":"Association between atopic dermatitis and hypertension: a systematic review and meta-analysis","volume":"186","author":"M Yousaf","year":"2022","journal-title":"Br J Dermatol"},{"issue":"4","key":"pone.0341337.ref036","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1346-8138.14218","article-title":"Burden of atopic dermatitis in Japanese adults: Analysis of data from the 2013 National Health and Wellness Survey","volume":"45","author":"K Arima","year":"2018","journal-title":"J Dermatol"},{"issue":"9","key":"pone.0341337.ref037","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/jdv.15642","article-title":"Atopic dermatitis and the metabolic syndrome: a cross-sectional study of 116 816 patients","volume":"33","author":"G Shalom","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"pone.0341337.ref038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.07.017","article-title":"Association of atopic dermatitis with smoking: A systematic review and meta-analysis","volume":"75","author":"R Kantor","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"pone.0341337.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.11.023","article-title":"Eczema and cardiovascular risk factors in 2 US adult population studies","volume":"135","author":"JI Silverberg","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"pone.0341337.ref040","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"CF Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0341337.ref041","doi-asserted-by":"crossref","first-page":"108983","DOI":"10.1016\/j.clim.2022.108983","article-title":"Increased plasma miR-24 and miR-191 levels in patients with severe atopic dermatitis: Possible involvement of platelet activation","volume":"237","author":"M Maeno","year":"2022","journal-title":"Clin Immunol"},{"issue":"4","key":"pone.0341337.ref042","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2332\/allergolint.O-08-537","article-title":"Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4","volume":"57","author":"R Tamagawa-Mineoka","year":"2008","journal-title":"Allergol Int"},{"issue":"3","key":"pone.0341337.ref043","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.clim.2009.01.006","article-title":"Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis","volume":"131","author":"R Tamagawa-Mineoka","year":"2009","journal-title":"Clin Immunol"},{"issue":"6","key":"pone.0341337.ref044","article-title":"American Academy of Dermatology Guidelines: Awareness of comorbidities associated with atopic dermatitis in adults","volume":"86","author":"DMR Davis","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"pone.0341337.ref045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.alit.2020.02.006","article-title":"Japanese guidelines for atopic dermatitis 2020","volume":"69","author":"N Katoh","year":"2020","journal-title":"Allergol Int"},{"issue":"5","key":"pone.0341337.ref046","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1253\/circj.CJ-23-0285","article-title":"JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease","volume":"88","author":"A Fujiyoshi","year":"2024","journal-title":"Circ J"},{"issue":"6","key":"pone.0341337.ref047","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022","volume":"31","author":"T Okamura","year":"2024","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"pone.0341337.ref048","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/1346-8138.17643","article-title":"Prevalence and incidence of comorbidities in patients with atopic dermatitis, psoriasis, alopecia areata, and vitiligo using a Japanese claims database","volume":"52","author":"Y Ma","year":"2025","journal-title":"J Dermatol"},{"issue":"10","key":"pone.0341337.ref049","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.2018.12115","article-title":"Case-Control Studies: Using \u201cReal-world\u201d Evidence to Assess Association","volume":"320","author":"TZ Irony","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"pone.0341337.ref050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/EDE.0b013e3182093a0f","article-title":"Time-window bias in case-control studies: statins and lung cancer","volume":"22","author":"S Suissa","year":"2011","journal-title":"Epidemiology"},{"issue":"4","key":"pone.0341337.ref051","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2188\/jea.13.193","article-title":"Selecting controls for assessing interaction in nested case-control studies","volume":"13","author":"J Cologne","year":"2003","journal-title":"J Epidemiol"},{"issue":"9","key":"pone.0341337.ref052","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/1346-8138.16485","article-title":"Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate-to-severe atopic dermatitis: Two-year data from the ADDRESS-J disease registry","volume":"49","author":"N Katoh","year":"2022","journal-title":"J Dermatol"},{"issue":"4","key":"pone.0341337.ref053","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1346-8138.14787","article-title":"Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden","volume":"46","author":"N Katoh","year":"2019","journal-title":"J Dermatol"},{"issue":"2","key":"pone.0341337.ref054","first-page":"338","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"LF Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:47:58Z","timestamp":1769194078000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341337"}},"subtitle":[],"editor":[{"given":"Seyed Aria","family":"Nejadghaderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341337","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}